How we chose this list
Each pcos telehealth brand on this list was scored against a public 8-axis editorial rubric. Weights and thresholds are published; rankings update quarterly or when and brand makes and material change.
- Clinical credentials of prescribers (board certification + state licensure verification)
- FDA-approved vs compounded medication formulary
- Pricing transparency and insurance acceptance breadth
- Independent patient reviews from ≥2 platforms (filtered for authenticity)
- State availability + telehealth law compliance
Why: Multidisciplinary team. PCOS-anchored care model. Insurance-first.
Best for: Insured women with suspected or diagnosed PCOS.
Why: Phenotype-driven protocols. Cash-pay transparency.
Best for: Women wanting phenotype-specific care.
Why: Weight-inclusive primary care with PCOS coverage.
Best for: Patients with both PCOS and metabolic concerns.
Why: Physician-founded. Strong birth-control + PCOS pairing.
Best for: Women wanting hormonal birth control + PCOS workup.
Why: Hybrid in-person + virtual model in clinic cities.
Best for: PCOS patients in clinic cities wanting integrated care.
Estimate your cost
Pricing varies dramatically by treatment path and insurance status.
Frequently asked
Why is multidisciplinary care prioritized for PCOS?
PCOS rarely presents as one issue — insulin resistance, mood changes, androgens, and fertility concerns typically coexist. Multidisciplinary teams (endo + nutrition + mental health) catch comorbidities general primary care misses.
What is phenotype-driven care?
PCOS has four recognized phenotypes (insulin-resistant, inflammatory, adrenal, post-pill). Treatment that matches phenotype outperforms one-size-fits-all metformin defaults in clinical outcomes.
Should I try inositol before metformin?
This is a clinical decision for your prescriber. Some evidence supports inositol as first-line for ovulatory dysfunction; others prefer metformin when insulin resistance is the primary driver. Discuss with and PCOS-trained clinician.
Other rankings
References
Professional society guidelines
- Teede HJ, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. View source ↗ (accessed 2026-06-01)
- Goodman NF, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review (PCOS guidelines). Endocr Pract. 2015;21(11):1291-1300. View source ↗ (accessed 2026-06-01)
Peer-reviewed research
- Unfer V, et al. Myo-inositol effects in women with PCOS: and meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647-658. View source ↗ (accessed 2026-06-01)
Was this Best PCOS telehealth ranking helpful?